CBmed Biomarker Research: Clinical Studies in the Diabetes Outpatient Department<\/h1><\/h1><\/div>- <\/i><\/span>\n
Two weeks after project start, first form processes were already active<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
3-months pilot project with 20 users and 150 patients<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
Successful productive operation for over 5 years with more than 1,300 patients<\/p>\n<\/div><\/li><\/ul><\/div><\/div><\/div><\/div>
The Medical University of Graz captures patient data for diabetes research digitally and in a structured way with HybridForms.<\/strong> Data from patients’ written informed consent forms, results of medical visits, and protocols of medical examinations are captured digitally with tablets for the biomarker research diabetes registry.<\/span><\/p>\n<\/div>HybridForms: Digital forms in medicine & research<\/h2><\/div>The goal of the diabetes registry for biomarker research<\/strong> is to capture a representative cohort of patients routinely treated at the University Hospital Graz. Consents for participation in the clinical trials as well as data from individual medical visits and patient interviews are collected on tablets using the HybridForms mobile App.<\/p>\nAll results are securely archived and transfered pseudonymized via interface to the clinical trial software.<\/strong> During pseudonymization, the patient\u2019s name is replaced by a pseudonym (Study Subject ID) to protect the identity of individual patients. However, this procedure preserves the references between different data sets for further analysis.<\/p>\nDigitization makes all data available more quickly for further evaluations and scientific research<\/strong> \u2013 and the error rate is minimized thanks to transparent and consistently traceable documentation.<\/p>\n<\/div><\/div><\/div>About CBmed Biomarker Research<\/h3><\/div>CBmed (Center for Biomarker Research in Medicine)<\/strong> combines excellent research infrastructure, scientific competence, medical expertise, national and international companies for systematic biomarker research in medicine.
\nCBmed thus contributes to the development of technologies with which diseases can be diagnosed at an early stage and thus treated \u2013 including cancer, diabetes and heart attacks.
\nThe competence center is owned by, among others, the Medical University of Graz and the Medical University of Vienna.<\/p>\nThe project \u00bbClinical Studies in the Diabetes Outpatient Department\u00ab was carried out by the HybridForms integration partner Kapsch BusinessCom<\/strong>.
\nKapsch BusinessCom supports inter\u00adnational companies and organizations in Smart Hospital, Health & Social Care with the digital trans\u00adformation and optimization of their processes.<\/p>\n<\/div><\/div><\/div><\/div><\/div>Digital informed consent & protocols of medical visits for the diabetes outpatient department at the Medical University of Graz with HybridForms<\/h2><\/div><\/div><\/div>![\"CBmed:](\"https:\/\/www.hybridforms.net\/en\/wp-content\/uploads\/sites\/3\/2024\/08\/HybridForms-CBmed-Diabetes-63.png\" "\\"CBmed:")
<\/span><\/div><\/div><\/div><\/div>![\"CBmed:](\"https:\/\/www.hybridforms.net\/en\/wp-content\/uploads\/sites\/3\/2024\/08\/HybridForms-CBmed-Diabetes-Mobil-63.png\" "\\"CBmed:")
<\/span><\/div><\/div><\/div><\/div>More about digital documentation in healthcare & research<\/span><\/i><\/a><\/div><\/div><\/div><\/div><\/div>![\"Harald](\"https:\/\/www.hybridforms.net\/en\/wp-content\/uploads\/sites\/3\/2018\/09\/CBmed-Harald-Sourij.jpg\")
<\/div>\n\u00bbThe tablet-based data entry with HybridForms allows us to perform data collection in the Diabetes Biomarker Research Registry much faster, more efficiently and much more securely. I am convinced that we will come across this model very frequently in other future research projects.\u00ab<\/p>\n<\/div><\/div><\/blockquote>
Univ.-Prof. Dr.med. Harald Sourij | Clinical Department of Endocrinology and Diabetology<\/strong>, Medical University of Graz<\/span><\/a><\/span><\/div><\/div><\/div><\/div><\/div><\/div>![\"Martin](\"https:\/\/www.hybridforms.net\/en\/wp-content\/uploads\/sites\/3\/2021\/11\/Kapsch-Martin-Schober-02.jpg\")
<\/div>\n\u00bbAs an implementation partner, HybridForms allows us to focus fully on our customers’ challenges \u2013 and thus achieve outstanding project results in short lead times.\u00ab<\/p>\n<\/div><\/div><\/blockquote>
Dipl.-Ing. Martin Schober | Head of Software Development Region South<\/strong>, K-Businesscom<\/span><\/a><\/span><\/div><\/div><\/div><\/div><\/div><\/div>![\"Logo](\"https:\/\/www.hybridforms.net\/en\/wp-content\/uploads\/sites\/3\/2021\/11\/Logo-CBmed-02.png\")
<\/a><\/span><\/div><\/div><\/div><\/div>![\"Logo](\"https:\/\/www.hybridforms.net\/en\/wp-content\/uploads\/sites\/3\/2021\/11\/Logo-MedUni-Graz-02.png\")
<\/a><\/span><\/div><\/div><\/div><\/div>![\"Logo](\"https:\/\/www.hybridforms.net\/en\/wp-content\/uploads\/sites\/3\/2022\/09\/Logo-Kapsch-Businesscom-02.png\")
<\/a><\/span><\/div><\/div><\/div><\/div><\/div><\/div>![\"CBmed:](\"https:\/\/www.hybridforms.net\/en\/wp-content\/uploads\/sites\/3\/2024\/08\/Form-Paper-Digital-CBmed-60.png\" "\\"Digital")
<\/span><\/div><\/div><\/div><\/div><\/div>Intelligent data acquisition in medicine and research: mobile, cross-platform & user-friendly \u2013 for traceability in the documentation of processes<\/h2><\/div><\/div><\/div>Requirements<\/h3><\/div>Until now, paper survey forms were used for clinical studies and the data was recorded by hand by the study personnel. In the case of longer studies, thousands of individual protocols often had to be collected on paper, subsequently typed or scanned so that they were available in the clinical database. If archiving was done in file folders, later search and evaluation was only possible with considerable effort.<\/strong><\/p>\nIn addition to the large amounts of paper that had to be kept, the subsequent transfer to the databases was a frequent source of errors that could lead to repeatedly incorrect \u2013 and thus unusable \u2013 data. Also, the possibilities for further important annotations were limited on the paper forms.<\/p>\n<\/div><\/div><\/div>
Solution with HybridForms already in the pilot project<\/h3><\/div>- <\/i><\/span>Digitization workshop<\/strong> by HybridForms Solution Partner Kapsch BusinessCom with process analysis and design of a digital prototype.<\/div><\/li>
- <\/i><\/span>Secure pilot project on servers of the Medical University of Graz<\/strong> in real process with selected pilot users and patients.<\/div><\/li>
- <\/i><\/span>Go live<\/strong> of the digital form processes tested in everyday clinical use directly after the pilot project, running since 2015.<\/div><\/li>
- <\/i><\/span>Direct added value through secure enterprise features<\/strong> such as biometric signatures, interactive assistance functions, and plausibility checks.<\/div><\/li><\/ul><\/div><\/div>
Learning and benefits in daily clinical use<\/h3><\/div>- <\/i><\/span>\n
Extremely reduced lead times<\/strong> and fast digital availability<\/p>\n<\/div><\/li>- <\/i><\/span>High data quality<\/strong> with checking during input and thus fewer errors<\/div><\/li>
- <\/i><\/span>Pseudonymization<\/strong> and secure protocol storage immediately after capture<\/div><\/li>
- <\/i><\/span>Complete digital data<\/strong> for research and scientific analysis<\/div><\/li><\/ul><\/div><\/div>More on the Pilot Project (PoC)<\/span><\/i><\/a><\/div><\/div><\/div><\/div><\/div>
![\"HybridForms:](\"https:\/\/www.hybridforms.net\/en\/wp-content\/uploads\/sites\/3\/2018\/09\/CBmed-Team.jpg\")
<\/a><\/span><\/div><\/div><\/div><\/div><\/div><\/div>HybridForms App & Software with secure enterprise features: \u00bbTablet instead of clipboard\u00ab for higher data quality, more transparency & more efficient clinical processes<\/h2><\/div><\/div><\/div>Biometrically secure signature<\/h3><\/div><\/a><\/div>- <\/i><\/span>Handwritten signatures with pen directly on the tablet<\/div><\/li>
- <\/i><\/span>\n
Storing the biometric characteristics according to ISO 19794-7<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
GDPR compliant encryption of biometrics directly on the device<\/p>\n<\/div><\/li><\/ul>
<\/div>Authentic: Legally binding consent and documentation<\/strong><\/p>\n<\/div>
- <\/i><\/span>\n
Two weeks after project start, first form processes were already active<\/p>\n<\/div><\/li>
- <\/i><\/span>
\n3-months pilot project with 20 users and 150 patients<\/p>\n<\/div><\/li>
- <\/i><\/span>
\nSuccessful productive operation for over 5 years with more than 1,300 patients<\/p>\n<\/div><\/li><\/ul><\/div><\/div><\/div><\/div>
The Medical University of Graz captures patient data for diabetes research digitally and in a structured way with HybridForms.<\/strong> Data from patients’ written informed consent forms, results of medical visits, and protocols of medical examinations are captured digitally with tablets for the biomarker research diabetes registry.<\/span><\/p>\n<\/div>
HybridForms: Digital forms in medicine & research<\/h2><\/div>
The goal of the diabetes registry for biomarker research<\/strong> is to capture a representative cohort of patients routinely treated at the University Hospital Graz. Consents for participation in the clinical trials as well as data from individual medical visits and patient interviews are collected on tablets using the HybridForms mobile App.<\/p>\n
All results are securely archived and transfered pseudonymized via interface to the clinical trial software.<\/strong> During pseudonymization, the patient\u2019s name is replaced by a pseudonym (Study Subject ID) to protect the identity of individual patients. However, this procedure preserves the references between different data sets for further analysis.<\/p>\n
Digitization makes all data available more quickly for further evaluations and scientific research<\/strong> \u2013 and the error rate is minimized thanks to transparent and consistently traceable documentation.<\/p>\n<\/div><\/div><\/div>
About CBmed Biomarker Research<\/h3><\/div>
CBmed (Center for Biomarker Research in Medicine)<\/strong> combines excellent research infrastructure, scientific competence, medical expertise, national and international companies for systematic biomarker research in medicine.
\nCBmed thus contributes to the development of technologies with which diseases can be diagnosed at an early stage and thus treated \u2013 including cancer, diabetes and heart attacks.
\nThe competence center is owned by, among others, the Medical University of Graz and the Medical University of Vienna.<\/p>\nThe project \u00bbClinical Studies in the Diabetes Outpatient Department\u00ab was carried out by the HybridForms integration partner Kapsch BusinessCom<\/strong>.
\nKapsch BusinessCom supports inter\u00adnational companies and organizations in Smart Hospital, Health & Social Care with the digital trans\u00adformation and optimization of their processes.<\/p>\n<\/div><\/div><\/div><\/div><\/div>Digital informed consent & protocols of medical visits for the diabetes outpatient department at the Medical University of Graz with HybridForms<\/h2><\/div><\/div><\/div>
<\/span><\/div><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/div>More about digital documentation in healthcare & research<\/span><\/i><\/a><\/div><\/div><\/div><\/div><\/div><\/div>\n\u00bbThe tablet-based data entry with HybridForms allows us to perform data collection in the Diabetes Biomarker Research Registry much faster, more efficiently and much more securely. I am convinced that we will come across this model very frequently in other future research projects.\u00ab<\/p>\n<\/div><\/div><\/blockquote>
Univ.-Prof. Dr.med. Harald Sourij | Clinical Department of Endocrinology and Diabetology<\/strong>, Medical University of Graz<\/span><\/a><\/span><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n\u00bbAs an implementation partner, HybridForms allows us to focus fully on our customers’ challenges \u2013 and thus achieve outstanding project results in short lead times.\u00ab<\/p>\n<\/div><\/div><\/blockquote>
Dipl.-Ing. Martin Schober | Head of Software Development Region South<\/strong>, K-Businesscom<\/span><\/a><\/span><\/div><\/div><\/div><\/div><\/div><\/div><\/a><\/span><\/div><\/div><\/div><\/div><\/a><\/span><\/div><\/div><\/div><\/div><\/a><\/span><\/div><\/div><\/div><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/div><\/div>Intelligent data acquisition in medicine and research: mobile, cross-platform & user-friendly \u2013 for traceability in the documentation of processes<\/h2><\/div><\/div><\/div>
Requirements<\/h3><\/div>
Until now, paper survey forms were used for clinical studies and the data was recorded by hand by the study personnel. In the case of longer studies, thousands of individual protocols often had to be collected on paper, subsequently typed or scanned so that they were available in the clinical database. If archiving was done in file folders, later search and evaluation was only possible with considerable effort.<\/strong><\/p>\n
In addition to the large amounts of paper that had to be kept, the subsequent transfer to the databases was a frequent source of errors that could lead to repeatedly incorrect \u2013 and thus unusable \u2013 data. Also, the possibilities for further important annotations were limited on the paper forms.<\/p>\n<\/div><\/div><\/div>
Solution with HybridForms already in the pilot project<\/h3><\/div>
- <\/i><\/span>Digitization workshop<\/strong> by HybridForms Solution Partner Kapsch BusinessCom with process analysis and design of a digital prototype.<\/div><\/li>
- <\/i><\/span>
Secure pilot project on servers of the Medical University of Graz<\/strong> in real process with selected pilot users and patients.<\/div><\/li>- <\/i><\/span>
Go live<\/strong> of the digital form processes tested in everyday clinical use directly after the pilot project, running since 2015.<\/div><\/li>- <\/i><\/span>
Direct added value through secure enterprise features<\/strong> such as biometric signatures, interactive assistance functions, and plausibility checks.<\/div><\/li><\/ul><\/div><\/div>Learning and benefits in daily clinical use<\/h3><\/div>
- <\/i><\/span>\n
Extremely reduced lead times<\/strong> and fast digital availability<\/p>\n<\/div><\/li>
- <\/i><\/span>
High data quality<\/strong> with checking during input and thus fewer errors<\/div><\/li>- <\/i><\/span>
Pseudonymization<\/strong> and secure protocol storage immediately after capture<\/div><\/li>- <\/i><\/span>
Complete digital data<\/strong> for research and scientific analysis<\/div><\/li><\/ul><\/div><\/div>More on the Pilot Project (PoC)<\/span><\/i><\/a><\/div><\/div><\/div><\/div><\/div><\/a><\/span><\/div><\/div><\/div><\/div><\/div><\/div>HybridForms App & Software with secure enterprise features: \u00bbTablet instead of clipboard\u00ab for higher data quality, more transparency & more efficient clinical processes<\/h2><\/div><\/div><\/div>
Biometrically secure signature<\/h3><\/div><\/a>
<\/div>- <\/i><\/span>Handwritten signatures with pen directly on the tablet<\/div><\/li>
- <\/i><\/span>
\nStoring the biometric characteristics according to ISO 19794-7<\/p>\n<\/div><\/li>
- <\/i><\/span>
\nGDPR compliant encryption of biometrics directly on the device<\/p>\n<\/div><\/li><\/ul>
<\/div>Authentic: Legally binding consent and documentation<\/strong><\/p>\n<\/div>
- <\/i><\/span>
- <\/i><\/span>
- <\/i><\/span>
- <\/i><\/span>